IP Library › Granted Patent US 9,844,675
Granted Patent B2
US 9,844,675 · App. 15/143,038 · Granted Dec 19, 2017

Enabling and disabling anti-tachyarrhythmia pacing in a concomitant medical device system

Inventors: Scott A. Hareland (Lino Lakes, MN); James K. Carney (Falcon Heights, MN); James D. Reinke (Maple Grove, MN); Jon D. Schell (Shoreview, MN); Barbara J. Schmid (Forest Lake, MN)
Assignee: Medtronic, Inc.
A61N1/3621A61N1/3756A61N1/37252A61N1/3962A61N1/3987
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,844,675
App. No.
15/143,038
Filed
Apr 29, 2016
Granted
Dec 19, 2017
Kind
B2
Art Unit
3762
USPC
607/4
Abstract

An implantable medical device comprising a signal generator configured to generate and deliver anti-tachyarrhythmia pacing (ATP) to a heart of a patient and processing circuitry. The processing circuitry is configured to detect an enable event, responsive to detecting the enable event, enable the delivery of ATP by the signal generator, detect a disable event indicating that another implantable medical device cannot be relied upon to deliver an anti-tachyarrhythmia shock, and responsive to detecting the disable event, disable delivery of ATP.

Claims (36)

1. A method comprising:

detecting, by an implantable medical device configured to deliver anti-tachyarrhythmia pacing (ATP) to a heart of a patient, an enable event;

responsive to detecting the enable event, enabling, by the implantable medical device, the delivery of ATP;

responsive to detecting the enable event, starting, by the implantable medical device, a timer;

detecting, by the implantable medical device, a disable event indicating that another implantable medical device cannot be relied upon to deliver an anti-tachyarrhythmia shock, wherein detecting the disable event comprises detecting that the timer has reached a time limit without requiring communication between the implantable medical device and the other implantable medical device; and

responsive to detecting the disable event, disabling, by the implantable medical device, delivery of ATP.

2. The method of claim 1 , wherein detecting the enable event comprises receiving, by the implantable medical device, an enable signal from an external device via wireless communication.

3. The method of claim 1 , wherein the enable event is a first enable event, further comprising:

detecting, by the implantable medical device after starting the timer, a second enable event; and

responsive to detecting the second enable event, restarting, by the implantable medical device, the timer.

4. The method of claim 3 ,

wherein detecting the second enable event comprises detecting the second enable event after disabling the delivery of ATP,

the method further comprising, responsive to detecting the second enable event, enabling, by the implantable medical device, delivery of ATP.

5. The method of claim 1 ,

wherein the implantable medical device comprises an intracardiac pacemaker configured for implantation in the heart, and

wherein the other implantable medical device comprises an extracardiovascular implantable cardiac defibrillator configured for extracardiovascular implantation in the patient.

6. The method of claim 1 , further comprising:

responsive to detecting the disable event, generating, by the implantable medical device, a disable alert.

7. A method comprising:

detecting, by an implantable medical device configured to deliver anti-tachyarrhythmia pacing (ATP) to a heart of a patient, an enable event;

responsive to detecting the enable event, enabling, by the implantable medical device, the delivery of ATP;

responsive to detecting the enable event, starting, by the implantable medical device, a timer;

detecting, by the implantable medical device, a disable event indicating that another implantable medical device cannot be relied upon to deliver an anti-tachyarrhythmia shock, wherein detecting the disable event comprises detecting that the timer has reached a time limit;

responsive to detecting the disable event, disabling, by the implantable medical device, delivery of ATP;

detecting, by the implantable medical device via a plurality of electrodes, cardiac therapy activity; and

modifying, by the implantable medical device, the timer based on detection of the cardiac therapy activity.

8. The method of claim 7 , wherein detecting the enable event comprises detecting, by the implantable medical device, a signal, wherein the signal is generated by the other implantable medical device.

9. The method of claim 8 , wherein detecting the enable event comprises detecting the signal via wireless communication.

10. The method of claim 7 ,

wherein detecting the cardiac therapy activity comprises detecting delivery of one or more anti-tachyarrhythmia shocks, and

wherein modifying the timer comprises shortening the time limit in response to detecting the delivery of the one or more anti-tachyarrhythmia shocks.

11. A method comprising:

detecting, by an implantable medical device configured to deliver anti-tachyarrhythmia pacing (ATP) to a heart of a patient, an enable event;

responsive to detecting the enable event, enabling, by the implantable medical device, the delivery of ATP;

detecting, by the implantable medical device, a disable event indicating that another implantable medical device cannot be relied upon to deliver an anti-tachyarrhythmia shock, wherein detecting the disable event comprises detecting delivery of a threshold number of anti-tachyarrhythmia shocks, thereby suggesting that the other implantable medical device cannot be relied upon to deliver an anti-tachyarrhythmia shock; and

responsive to detecting the disable event, disabling, by the implantable medical device, delivery of ATP.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2016
From: HARELAND, SCOTT A.; CARNEY, JAMES K.; REINKE, JAMES D.; SCHELL, JON D.; SCHMID, BARBARA J.
To: MEDTRONIC, INC.
Reel/Frame 038974/0113 →
Continuity (1)
Related Publication 20170312514A1 · Nov 2, 2017